Vangelis G. Alexiou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vangelis G. Alexiou has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Matthew E. Falagas
Alfa Institute of Biomedical Sciences, 15123 Athens, Greece
20 shared publications George Peppas
Alfa Institute of Biomedical Sciences (AIBS) 9 Neapoleos Street 151 23 Marousi Athens Greece
8 shared publicationsAreti Vassiliou
Department of Vascular Surgery, Attikon University Hospital , Athens
5 shared publicationsGeorge Geroulakos
School of Medicine, National and Kapodistrian University of Athens , Athens
4 shared publicationsAnna Ntanika
2nd Department of Surgery, General Children’s Hospital of Athens “P. & A. Kyriakou,” Athens, Greece
3 shared publications- Gregory C. Makris
Bayer AG London UK
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
A multi-guideline clinical agent for vascular surgery: architecture, implementation, and benchmark evaluation
Background: The clinical practice guidelines (CPGs) published by the European Society for Vascular Surgery (ESVS) span approximately 1100 pages whose simultaneous cross-referencing is impractical at the point of care. Unguarded large language models (LLMs) carry hallucination risk, motivating a guideline-locked design. Methods: We describe the architecture and development of a context-aware clinical agent encompassing the full ESVS corpus of 14 CPGs. The system extends a validated single-guideline GraphRAG prototype with an LLM-driven Guideline Router, an embedded Context Gate that withholds retrieval when decision-critical parameters are absent, dual-channel retrieval, and GPT-5 synthesis under a mandatory citation template. An automated benchmark assessed the final system on 55 vignettes, scored by 2 blinded LLM judges over 3 runs (330 judgments), with clinician adjudication of every flagged claim. Results: The system stayed within its locked corpus, declined all out-of-scope queries, and achieved 98.4% guideline-routing recall. The Context Gate showed 91.9% specificity and 78.6% sensitivity for underspecified queries, and all 259 cited recommendations were verifiable within the locked corpus. Automated judges flagged an unsupported claim in 18.2% of items under a sensitive screening definition; on adjudication by 2 vascular surgeons, 7.3% of items contained a clinically consequential error, none graded capable of causing harm. Clinical acceptability of complete answers was not scored and is reserved for prospective expert evaluation. Conclusion: These results support the feasibility of a multi-guideline context-aware clinical agent for vascular surgery; citation traceability and locked-corpus provenance facilitate future auditability.
- 3 November 2026
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
Open AccessA multi-guideline clinical agent for vascular surgery: architecture, implementation, and benchmark evaluation
Background: The clinical practice guidelines (CPGs) published by the European Society for Vascular Surgery (ESVS) span approximately 1100 pages whose simultaneous cross-referencing is impractical at the point of care. Unguarded large language models (LLMs) carry hallucination risk, motivating a guideline-locked design. Methods: We describe the architecture and development of a context-aware clinical agent encompassing the full ESVS corpus of 14 CPGs. The system extends a validated single-guideline GraphRAG prototype with an LLM-driven Guideline Router, an embedded Context Gate that withholds retrieval when decision-critical parameters are absent, dual-channel retrieval, and GPT-5 synthesis under a mandatory citation template. An automated benchmark assessed the final system on 55 vignettes, scored by 2 blinded LLM judges over 3 runs (330 judgments), with clinician adjudication of every flagged claim. Results: The system stayed within its locked corpus, declined all out-of-scope queries, and achieved 98.4% guideline-routing recall. The Context Gate showed 91.9% specificity and 78.6% sensitivity for underspecified queries, and all 259 cited recommendations were verifiable within the locked corpus. Automated judges flagged an unsupported claim in 18.2% of items under a sensitive screening definition; on adjudication by 2 vascular surgeons, 7.3% of items contained a clinically consequential error, none graded capable of causing harm. Clinical acceptability of complete answers was not scored and is reserved for prospective expert evaluation. Conclusion: These results support the feasibility of a multi-guideline context-aware clinical agent for vascular surgery; citation traceability and locked-corpus provenance facilitate future auditability.
- Open Access
- 3 August 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Accuracy and Readability of Generative Artificial Intelligence for Vascular Surgery Patients: A Specialist Based Evaluation Highlighting the Current Landscape of Safety Risks and Accessibility Gaps
- 3 August 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Open AccessAccuracy and Readability of Generative Artificial Intelligence for Vascular Surgery Patients: A Specialist Based Evaluation Highlighting the Current Landscape of Safety Risks and Accessibility Gaps
- 25 March 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 128, 473-483
An Artificial Intelligence Application for Standardized Expert-Level Interpretation of Vascular Clinical Practice Guidelines
- 25 March 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 128, 473-483
An Artificial Intelligence Application for Standardized Expert-Level Interpretation of Vascular Clinical Practice Guidelines
- 11 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (4) , 1844-1850
Hybrid boat-shaped and tubularized bovine patch conduit: A salvage solution for arteriovenous fistula creation
Background: Native arteriovenous fistulas remain the preferred vascular access for hemodialysis. However, critically unfavorable venous anatomy can impede their successful creation. Poor-quality or small-sized distal veins with areas of focal stenosis and thickened venous segments compromise the feasibility of placing a standard arteriovenous fistula or lead to fistula nonmaturation or malfunction, requiring adjuncts such as primary angioplasty or staged-balloon assisted maturation. Methods: This is a report of a single-stage technique using a short strip of bovine pericardium, tapered at the venous half of the patch in a “boat-shaped” configuration and flared at the arterial half of the patch, which is tubularized to create a cylindrical conduit and bridge an otherwise healthy vein with a focal stenosis to the target artery. With this onlay-tubularized bovine pericardial patch, the diseased segment can be enlarged and a smooth “neovein” created while preserving the autogenous cannulation segment. Results: The technique is illustrated in the case of a 56-year-old patient with immunoglobulin A nephropathy and a distal basilic vein focal defect. Immediate postoperative results were positive with strong bruit and thrill while follow-up duplex within 2 months showed excellent venous dilation and a flow exceeding 600 mL/min. Patency at 12 months remains intact. Conclusions: It is appropriate to use this technique in patients with adequate inflow and outflow, but with focal vein stenoses or short, thickened vein segments that preclude the use of a standard AVF. This hybrid approach, combining principles of patch venoplasty and bovine pericardial bypass grafting, may be used as a salvage option in selected patients with focal venous stenotic lesions considered for native arteriovenous fistula creation.
- 11 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (4) , 1844-1850
Hybrid boat-shaped and tubularized bovine patch conduit: A salvage solution for arteriovenous fistula creation
Background: Native arteriovenous fistulas remain the preferred vascular access for hemodialysis. However, critically unfavorable venous anatomy can impede their successful creation. Poor-quality or small-sized distal veins with areas of focal stenosis and thickened venous segments compromise the feasibility of placing a standard arteriovenous fistula or lead to fistula nonmaturation or malfunction, requiring adjuncts such as primary angioplasty or staged-balloon assisted maturation. Methods: This is a report of a single-stage technique using a short strip of bovine pericardium, tapered at the venous half of the patch in a “boat-shaped” configuration and flared at the arterial half of the patch, which is tubularized to create a cylindrical conduit and bridge an otherwise healthy vein with a focal stenosis to the target artery. With this onlay-tubularized bovine pericardial patch, the diseased segment can be enlarged and a smooth “neovein” created while preserving the autogenous cannulation segment. Results: The technique is illustrated in the case of a 56-year-old patient with immunoglobulin A nephropathy and a distal basilic vein focal defect. Immediate postoperative results were positive with strong bruit and thrill while follow-up duplex within 2 months showed excellent venous dilation and a flow exceeding 600 mL/min. Patency at 12 months remains intact. Conclusions: It is appropriate to use this technique in patients with adequate inflow and outflow, but with focal vein stenoses or short, thickened vein segments that preclude the use of a standard AVF. This hybrid approach, combining principles of patch venoplasty and bovine pericardial bypass grafting, may be used as a salvage option in selected patients with focal venous stenotic lesions considered for native arteriovenous fistula creation.
- 24 November 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 111, 260-267
Artificial Intelligence in Diagnosing and Managing Vascular Surgery Patients: An Experimental Study Using the GPT-4 Model
- 24 November 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 111, 260-267
Artificial Intelligence in Diagnosing and Managing Vascular Surgery Patients: An Experimental Study Using the GPT-4 Model
- 30 May 2024
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 39 (8) , 564-570
EndoVenous-assisted invaginated stripping of the great saphenous vein: A pilot and feasibility study
Objective: By incorporating an endovascular component into Great Saphenous Vein stripping, EndoVenous-assisted Invaginated Stripping (EVIS) aims to make the procedure minimally invasive. A study was conducted to investigate the surgical intervention. Methods: Sketches and videos were used to illustrate the technical aspects of EVIS. A prospective cohort study included 20 patients with chronic venous insufficiency (CVI). Results: EVIS is performed as a day-surgery. Technical success was 100%, and no complications were recorded. The mean operative time was 45 minutes, intraoperative pain score was 4.8, post-operative pain was 2.5, 1.8, 1.2, 0.5 at 48 hours, 1, 4, and 12 weeks, respectively. The mean blood loss was 15 mL, and the mean length of the GSV strapped was 19 cm. The follow-up duplex showed a reduction in the diameter of the residual GSV stump. Conclusions: EVIS is a combination of standard techniques that may prove valuable in managing CVI.
- 30 May 2024
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 39 (8) , 564-570
EndoVenous-assisted invaginated stripping of the great saphenous vein: A pilot and feasibility study
Objective: By incorporating an endovascular component into Great Saphenous Vein stripping, EndoVenous-assisted Invaginated Stripping (EVIS) aims to make the procedure minimally invasive. A study was conducted to investigate the surgical intervention. Methods: Sketches and videos were used to illustrate the technical aspects of EVIS. A prospective cohort study included 20 patients with chronic venous insufficiency (CVI). Results: EVIS is performed as a day-surgery. Technical success was 100%, and no complications were recorded. The mean operative time was 45 minutes, intraoperative pain score was 4.8, post-operative pain was 2.5, 1.8, 1.2, 0.5 at 48 hours, 1, 4, and 12 weeks, respectively. The mean blood loss was 15 mL, and the mean length of the GSV strapped was 19 cm. The follow-up duplex showed a reduction in the diameter of the residual GSV stump. Conclusions: EVIS is a combination of standard techniques that may prove valuable in managing CVI.
- 11 October 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (3) , 467
Losing A Limb Despite A Patent Peripheral Bypass!
- 11 October 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (3) , 467
Losing A Limb Despite A Patent Peripheral Bypass!
- 13 July 2022
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 54 (2) , 230-254
Conservative treatment vs thrombus removal for Iliofemoral vein thrombosis in patients with congenital abnormalities of the inferior vena cava: a case report and systematic review of the literature
Congenital abnormalities of the Inferior Vena Cava (IVC) should be suspected in cases of Deep Venous Thrombosis (DVT), especially in young patients, with no other risk factors and apparent causes. Currently, there is no guidance regarding the management of such patients. We report a case of Iliofemoral vein thrombosis in a young patient with congenital absence of the IVC that was successfully treated with catheter-directed thrombolysis (CDT) and perform a systematic review of the literature to identify evidence about the epidemiology, clinical presentation, management, and prognosis of this rare cause of DVT. A total of 42 studies reporting on 56 cases were included in the review. The mean age of the patients at the presentation of their first DVT episode is 23.6 years, 83.9% of patients were males, conservative management with anticoagulation was used in 68% of the reported cases, and thrombolysis was used in 32% of the cases. Only 10.7% of patients presented with PE potentially justified by the abnormal anatomy of the deep veins which makes the propagation of thrombi into the pulmonary arteries less possible. Comparing the long-term outcomes of the two treatment groups; 42.3% of the patients treated conservatively vs 15.4% of the patients treated with thrombolysis developed chronic symptoms (residual heaviness, pain, swelling, and cramping). 11.5% of patients who received conservative treatment developed post-thrombotic syndrome. None of the patients treated with thrombolysis developed post-thrombotic syndrome. There were no procedure-related complications and thrombolysis was well tolerated by the entirety of the thrombolysis treatment group. Recurrence of DVT occurred in 13% of the patients treated conservatively and in 7.7% of patients treated with thrombolysis. Thrombus removal by means of thrombolysis is the recommended treatment and can offer excellent short and long-term results. Anticoagulation with NOACs may be prescribed for life to prevent recurrence or for at least 6 months and then reconsidered following further evaluation of patients’ bleeding risk. It may be of value to organise an international registry for such patients. Guidelines issued by the relevant scientific societies will then be able to make a clear recommendation about the management of such patients.
- 13 July 2022
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 54 (2) , 230-254
Conservative treatment vs thrombus removal for Iliofemoral vein thrombosis in patients with congenital abnormalities of the inferior vena cava: a case report and systematic review of the literature
Congenital abnormalities of the Inferior Vena Cava (IVC) should be suspected in cases of Deep Venous Thrombosis (DVT), especially in young patients, with no other risk factors and apparent causes. Currently, there is no guidance regarding the management of such patients. We report a case of Iliofemoral vein thrombosis in a young patient with congenital absence of the IVC that was successfully treated with catheter-directed thrombolysis (CDT) and perform a systematic review of the literature to identify evidence about the epidemiology, clinical presentation, management, and prognosis of this rare cause of DVT. A total of 42 studies reporting on 56 cases were included in the review. The mean age of the patients at the presentation of their first DVT episode is 23.6 years, 83.9% of patients were males, conservative management with anticoagulation was used in 68% of the reported cases, and thrombolysis was used in 32% of the cases. Only 10.7% of patients presented with PE potentially justified by the abnormal anatomy of the deep veins which makes the propagation of thrombi into the pulmonary arteries less possible. Comparing the long-term outcomes of the two treatment groups; 42.3% of the patients treated conservatively vs 15.4% of the patients treated with thrombolysis developed chronic symptoms (residual heaviness, pain, swelling, and cramping). 11.5% of patients who received conservative treatment developed post-thrombotic syndrome. None of the patients treated with thrombolysis developed post-thrombotic syndrome. There were no procedure-related complications and thrombolysis was well tolerated by the entirety of the thrombolysis treatment group. Recurrence of DVT occurred in 13% of the patients treated conservatively and in 7.7% of patients treated with thrombolysis. Thrombus removal by means of thrombolysis is the recommended treatment and can offer excellent short and long-term results. Anticoagulation with NOACs may be prescribed for life to prevent recurrence or for at least 6 months and then reconsidered following further evaluation of patients’ bleeding risk. It may be of value to organise an international registry for such patients. Guidelines issued by the relevant scientific societies will then be able to make a clear recommendation about the management of such patients.
- 1 August 2020
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 67, 557-562
Carotid Endarterectomy Using a Flow-Reversal Technique in the Acute Period: A Novel Approach That May Reduce Intraoperative Cerebral Events
- 1 August 2020
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 67, 557-562
Carotid Endarterectomy Using a Flow-Reversal Technique in the Acute Period: A Novel Approach That May Reduce Intraoperative Cerebral Events